Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Audinate Group (AD8.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-03-30	6.83	10.30	Buy
2022-04-28	5.99	9.85	Buy
2022-08-22	8.80	10.20	Buy
2023-02-13	7.89	10.35	Buy
2023-08-22	12.46	13.55	Buy
2023-12-11	14.39	-	No Rating
2024-02-12	19.33	21.05	Buy
2024-03-21	22.50	-	No Rating
2024-03-26	20.90	21.05	Buy
2024-04-09	19.79	22.80	Buy
2024-08-07	8.28	10.90	Buy
2024-08-20	10.55	12.20	Neutral
2024-11-05	9.25	10.60	Neutral
2025-02-18	10.41	10.85	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.